COMMUNICATIONS
[29] a) C. M. Murray, T. R. Auton, M. D. Eldrige, J. Comput. Aided Mol.
Des. 1998, 12, 503 ± 519; b) H. J. Böhm, J. Comput. Aided Mol. Des.
1998, 12, 309 ± 323.
[30] The LeadQuest product description guarantees >85% purity for
every compound as determined by analytical HPLC (HP110 system)
using a universal water/acetonitrile gradient and a UV detector at
254 nm.
native-like binding geometries represents an important first
step towards this goal.
Finally, we have shown that the LeadQuest Database
provides an ideal source for the discovery of novel lead
compounds,[31] in terms of both structural diversity[8] and
chemical purity.[30]
[31] A search in the patent literature shows that the subnanomolar
compounds discovered here possess scaffolds not covered by existing
patents. Such
structureº.
a scaffold is generally accepted as a ªnew lead
Received: June 14, 2000 [Z15270]
[32] A. T. Brünger, X-PLOR, Version 3.1, Yale University Press, New
Haven, 1992.
[1] E. S. Lander, Science 1996, 274, 536 ± 539.
[2] R. Lahana, Drug Discov. Today 1999, 4, 447 ± 448.
[3] W. P. Walters, M. T. Stahl, M. A. Murcko, Drug Discov. Today 1998, 3,
160 ± 178.
[4] H. J. Böhm, G. Klebe, Angew. Chem. 1996, 108, 2750 ± 2778; Angew.
Chem. Int. Ed. Engl. 1996, 35, 2588 ± 2614.
[5] J. Sadowski, J. Gasteiger, G. Klebe, J. Chem. Inf. Comput. Sci. 1994, 34,
1000 ± 1008.
[6] Maybridge Database (Version August 99), Maybridge Chemical Co.
Ltd. (UK) 1999.
[7] LeadQuest Chemical Compound Libraries, Vol. 1 ± 3, Tripos, Inc. (St.
Louis, MO) 2000.
Thioformaldehyde S-sulfide (Thiosulfine)**
Â
Â
Grzegorz Mloston, Jaroslaw Romanski,
Hans Peter Reisenauer, and Günther Maier*
[8] D. E. Patterson, R. D. Cramer, A. M. Ferguson, R. D. Clark, L. E.
Weinberger, J. Med. Chem. 1996, 39, 3049 ± 3059.
[9] S. Lindskog, Pharmacol. Ther. 1997, 74, 1 ± 20.
[10] S. K. Nair, J. F. Krebs, D. W. Christianson, C. A. Fierke, Biochemistry
1995, 34, 3981 ± 3989.
[11] G. M. Smith, R. S. Alexander, D. W. Christianson, B. M. McKeever,
G. S. Ponticello, J. P. Springer, W. C. Randall, J. J. Baldwin, C. N.
Habecker, Protein Sci. 1994, 3, 118 ± 125.
[12] P. A. Boriack-Sjodin, S. Zeitlin, H. H. Chen, L. Crenshaw, S. Gross, A.
Dantanarayana, P. Delgado, J. A. May, T. Dean, D. W. Christianson,
Protein Sci. 1998, 7, 2483 ± 2489.
[13] L. R. Scolnick , A. M. Clements , J. Liao, L. Crenshaw, M. Hellberg, J.
May, T. R. Dean, D. W. Christianson, J. Am. Chem. Soc. 1997, 119,
850 ± 851.
[14] The following human CAII complexes (resolution < 2.5 ) were used
for superposition: 1am6, 1bcd, 1bn1, 1bn2, 1bn3, 1bn4, 1bnn, 1bnq,
1bnt, 1bnu, 1bnv, 1bnw, 1bv3, 1cil, 1cim, 1cin, 1cnw, 1cnx, 1cny, 1cra,
1okl, 1okm, 1okn, 3ca2.
The elucidation of the course of events in the ozonolysis of
olefins by Criegee[1] was a milestone in the effort to under-
stand the mechanism of organic reactions. As early as in 1949
it was recognized that carbonyl oxides are the decisive
intermediates in this process.[2] However, to date it has not
been possible to observe these species directly during the
transformation of ªprimaryº into ªsecondaryº ozonides. In
contrast, an entry into carbonyl oxides exists in the trapping of
carbenes with oxygen under matrix conditions;[3] however, the
unsubstituted formaldehyde O-oxide 1 cannot be isolated
even upon using this procedure. In the reaction of methylene
with oxygen in an argon matrix only formic acid was
detected.[4]
[15] M. Hendlich, Acta Crystallogr. Sect. D 1998, 45, 1178 ± 1182.
[16] P. J. Goodford, J. Med. Chem. 1984, 28, 849 ± 857.
[17] M. L. Verdonk, J. C. Cole, R. Taylor, J. Mol. Biol. 1999, 4, 1093 ±
1108.
[18] H. J. Böhm, J. Comput. Aided Mol. Des. 1992, 6, 61 ± 78.
[19] H. Gohlke, M. Hendlich, G. Klebe, J. Mol. Biol. 2000, 295, 337 ± 356.
[20] R. E. Babine, S. L. Bender, Chem. Rev. 1997, 97, 1359 ± 1472.
[21] UNITY Chemical Information Software, Version 4.1.1, Tripos, Inc.
(St. Louis, MO) 2000.
[22] S. Grüneberg, PhD thesis, Universität Marburg (Germany), 2000.
[23] C. Lemmen, T. Lengauer, G. Klebe, J. Med. Chem. 1998, 41, 4502 ±
4520.
[24] X. Fradera, R. M. A. Knegtel, J. Mestres, Proteins 2000, 40, 623 ± 636.
[25] H. Gohlke, PhD thesis, Universität Marburg, 2000.
[26] M. Rarey, B. Kramer, T. Lengauer, G. Klebe, J. Mol. Biol. 1996, 261,
470 ± 489.
The idea that it might be possible to generate formaldehyde
together with its oxide by cycloreversion of 1,2,4-trioxolane
has not yet been realized, presumably due to the fact that the
required ozonide of ethene is difficult to handle.[5] As is shown
herein,[6] the situation is completely different in the sulfur
series. 1,2,4-Trithiolane (3) is a stable, easily accessible
[27] P. R. Gerber, K. Müller, J. Comput. Aided Mol. Des. 1995, 9, 251 ± 268.
[28] Data for the inhibitor given in entry 7 in Table 1 were collected to a
resolution of 2.4 and a completeness of 81.3%. Phases were
calculated by using protein and water coordinates from 2cba. The
protein and inhibitor structure was refined[32] to an R value of 0.1918
for 8012 reflections with F > 2s (standard deviation for bond lengths
of 0.007 and for bond angles of 1.6378). Data for the inhibitor given
in entry 6 in Table 1 were collected to a resolution of 2.3 and a
completeness of 95.2%. Phases were calculated by using protein and
water coordinates from 2cba. The protein and inhibitor structure was
refined[32] to an R value of 0.1955 for 10124 reflections with F > 2s
(standard deviation for bond lengths of 0.008 and for bond angles of
1.4438).
[*] Prof. Dr. G. Maier, Dr. H. P. Reisenauer
Institut für Organische Chemie der Universität
Heinrich-Buff-Ring 58, 35392 Gieûen (Germany)
Fax : ( 49)641-99-34309
Â
Â
Prof. Dr. G. Mloston, Dr. J. Romanski
Institute of Organic and Applied Chemistry
University of Lodz
Narutowicza 68, 90136 Lodz (Poland)
[**] This work was supported by the Fonds der Chemischen Industrie, the
Deutsche Forschungsgemeinschaft, and the Polish State Committee
for Scientific Research (KBN Grant 3T09A00716).
Angew. Chem. Int. Ed. 2001, 40, No. 2
ꢀ WILEY-VCH Verlag GmbH, D-69451 Weinheim, 2001
1433-7851/01/4002-0393 $ 17.50+.50/0
393